Guangdong Marubi Biotechnology Co., Ltd. (SHA:603983)
China flag China · Delayed Price · Currency is CNY
29.11
-2.34 (-7.44%)
Sep 15, 2026, 1:05 PM CST

SHA:603983 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
1,4221,2502,0321,0771,073806.1
Short-Term Investments
-154.4244.08279.64333.41115.15
Trading Asset Securities
390.14388.66395.7767.98437.78738.09
Cash & Short-Term Investments
1,8121,7932,4722,1241,8441,659
Cash Growth
-9.39%-27.45%16.36%15.19%11.14%-33.37%
Accounts Receivable
28.6438.446.4331.573.9362.85
Other Receivables
29.2722.1211.5714.647.437.42
Receivables
57.960.525846.1481.3670.26
Inventory
196.59233.35219.66171.73151.7138.43
Prepaid Expenses
-9.1812.52--4.9
Other Current Assets
207.44139.34192.31187.75159.99102.88
Total Current Assets
2,2742,2362,9542,5302,2371,976
Property, Plant & Equipment
949.09931.771,082769.91520.59384.14
Long-Term Investments
180.21261.03217.8563.6173.8775.12
Other Intangible Assets
387.85394.15699.16719.58748.63764.56
Long-Term Deferred Tax Assets
132.3110.8391.8559.142.1621.67
Long-Term Deferred Charges
23.9121.231.743.172.589.98
Other Long-Term Assets
686.13658.5615.76308.41469.07530.38
Total Assets
4,6334,6135,0634,4544,0943,762

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Accounts Payable
251.14188.12253.14178.15152.94154.46
Accrued Expenses
23.83209.28167.8156.78156.8104.95
Short-Term Debt
407395790.1100.07100-
Current Portion of Long-Term Debt
0.83--148.12.1-
Current Portion of Leases
-0.832.364.058.654.79
Current Income Taxes Payable
43.4120.6932.6715.4527.9824.76
Current Unearned Revenue
169.33184.82195.12240.494.53144.57
Other Current Liabilities
274.71200.08155.34167.19125.47143.02
Total Current Liabilities
1,1701,1991,5971,010668.47576.55
Long-Term Debt
----148-
Long-Term Leases
1.581.981.53.2511.6814.68
Long-Term Unearned Revenue
4.054.245.396.165.569.51
Long-Term Deferred Tax Liabilities
19.5914.2512.2615.237.852.45
Other Long-Term Liabilities
--0.360.36--
Total Liabilities
1,1951,2191,6161,035841.56603.19

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Common Stock
401401401401401.44401.82
Additional Paid-In Capital
761765.28761760.45774.49780.12
Retained Earnings
2,2222,1672,2202,1872,0281,930
Treasury Stock
-----14.47-26.66
Comprehensive Income & Other
-2-1.73-1.71-1.58-1.49-1.28
Total Common Equity
3,3823,3313,3803,3473,1883,084
Minority Interest
55.8263.0266.171.4264.5174.36
Shareholders' Equity
3,4383,3943,4473,4193,2533,158
Total Liabilities & Equity
4,6334,6135,0634,4544,0943,762

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Total Debt
409.42397.81793.97255.48270.4419.47
Net Cash (Debt)
1,4021,3961,6781,8691,5741,640
Net Cash Growth
-3.31%-16.82%-10.22%18.75%-4.03%-31.21%
Net Cash Per Share
3.553.504.174.683.894.10
Filing Date Shares Outstanding
393.21401401401401.44401.82
Total Common Shares Outstanding
393.21401401401401.44401.82
Working Capital
1,1031,0371,3581,5201,5691,399
Book Value Per Share
8.608.318.438.357.947.68
Tangible Book Value
2,9942,9372,6812,6282,4392,320
Tangible Book Value Per Share
7.617.326.696.556.085.77
Buildings
-911.4507.12476.51274.43274.43
Machinery
-108.2693.0485.3973.5263.46
Construction In Progress
-22.89603.06309.48253.24118.62